News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
437,088 Results
Type
Article (29049)
Company Profile (158)
Press Release (407867)
Multimedia
Podcasts (120)
Webinars (17)
Section
Business (128225)
Career Advice (1269)
Deals (23068)
Drug Delivery (117)
Drug Development (61264)
Employer Resources (123)
FDA (9942)
Job Trends (9702)
News (226577)
Policy (21158)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (1535)
Academic (1)
Accelerated approval (20)
Adcomms (25)
Allergies (103)
Alliances (33797)
ALS (122)
Alzheimer's disease (1061)
Antibody-drug conjugate (ADC) (225)
Approvals (10148)
Artificial intelligence (336)
Autoimmune disease (96)
Automation (21)
Bankruptcy (206)
Best Places to Work (7180)
BIOSECURE Act (14)
Biosimilars (179)
Biotechnology (68)
Bladder cancer (90)
Brain cancer (40)
Breast cancer (369)
Cancer (2919)
Cardiovascular disease (307)
Career advice (1059)
Career pathing (29)
CAR-T (158)
CDC (29)
Celiac Disease (1)
Cell therapy (398)
Cervical cancer (18)
Clinical research (53319)
Collaboration (1145)
Company closure (2)
Compensation (405)
Complete response letters (53)
COVID-19 (1825)
CRISPR (58)
C-suite (598)
Cystic fibrosis (99)
Data (4167)
Decentralized trials (2)
Denatured (33)
Depression (104)
Diabetes (339)
Diagnostics (3068)
Digital health (18)
Diversity (12)
Diversity, equity & inclusion (36)
Drug discovery (187)
Drug pricing (205)
Drug shortages (34)
Duchenne muscular dystrophy (163)
Earnings (48333)
Editorial (57)
Employer branding (14)
Employer resources (116)
Events (63146)
Executive appointments (715)
FDA (11877)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (3)
Frontotemporal dementia (8)
Funding (845)
Gene editing (110)
Generative AI (35)
Gene therapy (354)
GLP-1 (908)
Government (2710)
Grass and pollen (6)
Guidances (250)
Healthcare (9582)
HIV (46)
Huntington's disease (34)
IgA nephropathy (62)
Immunology and inflammation (198)
Immuno-oncology (43)
Indications (78)
Infectious disease (2003)
Inflammatory bowel disease (144)
Inflation Reduction Act (12)
Influenza (66)
Intellectual property (144)
Interviews (192)
IPO (9349)
IRA (55)
Job creations (2734)
Job search strategy (929)
JPM (56)
Kidney cancer (10)
Labor market (66)
Layoffs (389)
Leadership (31)
Legal (4991)
Liver cancer (54)
Longevity (10)
Lung cancer (392)
Lymphoma (251)
Machine learning (26)
Management (46)
Manufacturing (573)
MASH (127)
Medical device (4718)
Medtech (4742)
Mergers & acquisitions (14370)
Metabolic disorders (1036)
Multiple sclerosis (122)
NASH (21)
Neurodegenerative disease (200)
Neuropsychiatric disorders (76)
Neuroscience (1949)
Neurotech (1)
NextGen: Class of 2026 (3719)
Non-profit (2181)
Now hiring (46)
Obesity (559)
Opinion (246)
Ovarian cancer (95)
Pain (166)
Pancreatic cancer (121)
Parkinson's disease (197)
Partnered (26)
Patents (290)
Patient recruitment (293)
Peanut (31)
People (41950)
Pharmaceutical (78)
Pharmacy benefit managers (33)
Phase 1 (16028)
Phase 2 (22844)
Phase 3 (18502)
Pipeline (3376)
Policy (259)
Postmarket research (1950)
Preclinical (5896)
Press Release (50)
Prostate cancer (171)
Psychedelics (33)
Radiopharmaceuticals (202)
Rare diseases (612)
Real estate (3864)
Recruiting (50)
Regulatory (16436)
Reports (30)
Research institute (1483)
Resumes & cover letters (187)
Rett syndrome (7)
RNA editing (12)
RSV (57)
Schizophrenia (127)
Series A (152)
Series B (110)
Service/supplier (9)
Sickle cell disease (75)
Special edition (21)
Spinal muscular atrophy (134)
Sponsored (23)
Startups (2561)
State (2)
Stomach cancer (13)
Supply chain (80)
Tariffs (94)
The Weekly (85)
Vaccines (664)
Venture capital (78)
Weight loss (402)
Women's health (53)
Worklife (12)
Date
Today (12)
Last 7 days (371)
Last 30 days (1356)
Last 365 days (18473)
2026 (1714)
2025 (18732)
2024 (21594)
2023 (24187)
2022 (32036)
2021 (33980)
2020 (32294)
2019 (27753)
2018 (21424)
2017 (21674)
2016 (20770)
2015 (24334)
2014 (18597)
2013 (15344)
2012 (16580)
2011 (17179)
2010 (15516)
Location
Africa (543)
Alabama (45)
Alaska (4)
Arizona (132)
Arkansas (8)
Asia (31207)
Australia (4545)
California (5941)
Canada (2074)
China (858)
Colorado (235)
Connecticut (242)
Delaware (207)
Europe (67812)
Florida (1023)
Georgia (185)
Hawaii (2)
Idaho (32)
Illinois (559)
India (59)
Indiana (352)
Iowa (7)
Japan (352)
Kansas (89)
Kentucky (31)
Louisiana (15)
Maine (15)
Maryland (793)
Massachusetts (4559)
Michigan (103)
Minnesota (325)
Mississippi (3)
Missouri (64)
Montana (15)
Nebraska (17)
Nevada (56)
New Hampshire (19)
New Jersey (2096)
New Mexico (24)
New York (1663)
North Carolina (916)
North Dakota (2)
Northern California (2812)
Ohio (171)
Oklahoma (10)
Oregon (26)
Pennsylvania (1297)
Puerto Rico (19)
Rhode Island (28)
South America (794)
South Carolina (19)
Southern California (2459)
Tennessee (79)
Texas (848)
United States (22342)
Utah (130)
Virginia (194)
Washington D.C. (64)
Washington State (521)
West Virginia (1)
Wisconsin (58)
Wyoming (2)
437,088 Results for "tanner pharma group".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
LSL PHARMA GROUP SUCCESSFULLY OBTAINED U.S. FDA CERTIFICATION FOR THE MANUFACTURING OF OPHTHALMIC OINTMENTS FOR COMMERCIALIZATION IN THE UNITED STATES
January 29, 2026
·
3 min read
Mergers & acquisitions
Big Pharma Dealmakers Joined by Spunky Group of Biotech Buyers in Q4
While Novartis secured the biggest deal of the fourth quarter, a handful of riveting tales emerged from the bottom of the M&A list, including a zombie buyout and a bidding war. And no, we’re not talking about Metsera.
January 2, 2026
·
2 min read
·
Annalee Armstrong
Press Releases
LSL PHARMA GROUP ANNOUNCES CLOSING OF THE ACQUISITION OF JUNO OTC AND FINAL $2M CLOSING OF UPSIZED $12M OFFERING
December 24, 2025
·
6 min read
Press Releases
As mental health patients turn to AI chatbots, how can pharma lead the way?
A new report by Bryter released today reveals where pharma can lead as patients turn to (and question) AI tools for mental health.
February 5, 2026
·
1 min read
Press Releases
LSL PHARMA GROUP REPORTS FOURTH CONSECUTIVE RECORD QUARTERLY REVENUES AND Q3 2025 FINANCIAL RESULTS
November 21, 2025
·
16 min read
Earnings
Roche Plans To Go Toe-to-Toe With Novo, Lilly in Obesity
Roche aims to become a “top three player” in obesity, Teresa Graham, CEO of the group’s Pharma unit, said Thursday during a presentation of the company’s full-year 2025 earnings.
January 29, 2026
·
2 min read
Bio NC
ORPHELIA Pharma Selects Tanner Pharma Group to Initiate Named Patient Program for KIMOZO® (temozolomide) in European Countries
ORPHELIA Pharma and Tanner Pharma Group have signed an exclusive agreement to manage the supply and distribution of Ped-TMZ, also known as KIMOZO®, to meet the special demands which may come from physicians for this unapproved pediatric form of temozolomide.
April 18, 2023
·
2 min read
Press Releases
Tanner Pharma Expands Global Access to Botensilimab and Balstilimab Through Partnership With Agenus
December 12, 2024
·
2 min read
Drug pricing
Sanofi Joins Growing Group of Pharmas Pulling Back From UK
Merck, Eli Lilly and AstraZeneca have similarly suspended or outright canceled investments in the U.K. in the past week after a sizeable increase in a mandatory levy in the region.
September 16, 2025
·
2 min read
·
Tristan Manalac
Japan
Japanese Pharmas Looking Beyond Borders for M&A to US, EU
Long a quieter, locally focused industry, Japanese pharma giants are increasingly looking to the rest of the world for deals.
December 10, 2025
·
7 min read
·
Dan Samorodnitsky
1 of 43,709
Next
